Skip to main content

Advertisement

SpringerLink
Log in

Clinical applications of monoclonal antibodies

  • Review
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

This review highlights the properties, problems, and potentials of monoclonal antibodies as diagnostic and therapeutic agents. The most extensive experience has been obtained with antibodies specific for functionally distinct subsets of lymphocytes. They have been used to monitor the immunosuppression of organ-graft recipients and to attempt to elucidate the disturbance of immunologie function in a variety of conditions. Current therapeutic applications under trial include immunosuppression to treat organ-graft rejection and to eliminate cells responsible for graft-vs-host disease from the bone marrow. Applications to cancer diagnosis and treatment have been hampered by the difficulty of identifying truly tumor-specific antigens. Successes have, however, been obtained in the location of metastases and in the extracorporeal treatment of autologous marrow to purge it of malignant cells, and, more rarely, with the direct administration of monoclonal antibodies in vivo. The conjugation of cell-type specific monoclonal antibodies with cytotoxic agents should overcome a number of limitations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Albertini, A., Ekins, R. (ed): Monoclonal antibodies and developments in immunoassay. Elsevier North Holland Biomedical Press, Amsterdam, 1980.

    Google Scholar 

  2. Kennett, R. H., McKearn, T. J., Bechtol, K. B. (ed): Monoclonal antibody hybridomas: a new dimension in biological analysis. Plenum, New York, 1980.

    Google Scholar 

  3. Kennett, R. H.: Hybridomas: a new dimension in biological analysis. In Vitro 1981, 17: 1036–1050.

    PubMed  Google Scholar 

  4. Fellows, R. E., Eisenbarth, G. S. (ed): Monoclonal antibodies in endocrine research. Raven Press, New York, 1981.

    Google Scholar 

  5. McMichael, A. J., Fabre, J. W. (ed): Monoclonal antibodies in clinical medicine. Academic Press, New York, 1982.

    Google Scholar 

  6. Reinherz, E. L., Schlossman, S. F.: The characterization and function of human immunoregulatory subsets. Pharmacological Reviews 1982, 34: 17–22.

    PubMed  Google Scholar 

  7. Nowinski, R. C., Tam, M. R., Goldstein, L. C., Stong, L., Kuo, C.-C., Corey, L., Stamm, W. E., Handsfield, H. H., Knapp, J. S., Holmes, K. K.: Monoclonal antibodies for diagnosis of infectious diseases in humans. Science 1983, 219: 637–644.

    PubMed  Google Scholar 

  8. Boss, B. D., Langman, R., Trowbridge, I. S., Dulbecco, R. (ed.): Monoclonal antibodies and cancer. Academic Press, New York, 1983, p. 187–198.

    Google Scholar 

  9. Ritz, J.: Use of monoclonal antibodies in autologous and allogeneic bone marrow transplantation. Clinics in Haematology 1983, 12: 813–832.

    PubMed  Google Scholar 

  10. Oldham, R. K.: Monoclonal antibodies in cancer therapy. Journal of Clinical Oncology 1983, 1: 582–590.

    PubMed  Google Scholar 

  11. Russell, P. S., Colvin, R. B., Cosimi, A. B.: Monoclonal antibodies for the diagnosis and treatment of transplant rejection. Annual Review of Medicine 1984, 35: 63–79.

    PubMed  Google Scholar 

  12. Ekins, R.: Towards immunoassays of greater sensitivity, specificity and speed: an overview. In: Albertini, A., Ekins, R. (ed.): Monoclonal antibodies and developments in immunoassay. Elsevier North Holland Biomedical Press, Amsterdam, 1980, p. 3–21.

    Google Scholar 

  13. Boehringer Mannheim GmbH: Boehringer Mannheim Biochemicals Catalog 1984–1985. Boehringer Mannheim GmbH, Mannheim, 1984.

    Google Scholar 

  14. Gozes, I., Melner, R. J., Liu, F. T., Johnson, E., Batterberg, E. G., Katz, D. H., Bloom, F. E.: Monoclonal antibodies against vasoactive intestinal polypeptides: studies of structure and related antigens. Journal of Neurochemistry 1983, 41: 549–545.

    PubMed  Google Scholar 

  15. Accolla, R. S., Carrel, S., Mach, J.-P.: Monoclonal antibodies specific for carcino-embryonic antigen and produced by two hybrid cell lines. Proceedings of the National Academy of Sciences of the USA 1980, 77: 563–566.

    PubMed  Google Scholar 

  16. Hunter, M. M., Margolies, M. N., Ju, A., Habers, E.: Highaffinity monoclonal antibodies to the cardiac glycoside, digoxin. Journal of Immunology 1982, 129: 1165–1172.

    Google Scholar 

  17. Gerhard, W., Yewdell, J. W., Frankel, M., Webster, R. G.: Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 1981, 290: 713–717.

    PubMed  Google Scholar 

  18. Koprowski, H., Wiktor, T.: Monoclonal antibodies against rabies virus. In: Kennett, R. H., McKearn, T. J., Bechtol, K. B. (ed.): Monoclonal antibody hybridomas: a new dimension in biological analysis. Plenum, New York, 1980, p. 335–351.

    Google Scholar 

  19. Herbst, H., Lavanchy, D., Braun, D. G.: Grouping of haemolytic streptococci by monoclonal antibodies: determinant specificity, cross reactivity and affinity. Annales d'Immunologie (D) 1983, 134: 349–371.

    Google Scholar 

  20. Polin, R. A.: Monoclonal antibodies against streptococcal antigens. In: Kennett, R. H., McKearn, T. J., Bechtol, K. B. (ed.): Monoclonal antibody hybridomas: a new dimension in biological analysis. Plenum, New York, 1980, p. 353–359.

    Google Scholar 

  21. Lennox, E. S., Sikora, K.: Definition of human tumor antigens. In: McMichael, A. J., Fabre, J. W. (ed.): Monoclonal antibodies in clinical medicine. Academic Press, New York, 1982, p. 111–128.

    Google Scholar 

  22. Reinherz, E. L., Schlossman, S. F.: Con A inducible suppression of MLC: evidence for mediation by the TH2 T cell subset in man. Journal of Immunology 1979, 122: 1335–1341.

    Google Scholar 

  23. Morimoto, C., Reinherz, E. L., Borel, Y., Schlossman, S. F.: Direct demonstration of the human suppression inducer subset by anti-T cell antibodies. Journal of Immunology 1983, 130: 157–161.

    Google Scholar 

  24. Goldstein, G., Lifter, J., Mittler, R.: Immunoregulatory changes in human disease detected by monoclonal antibodies to T lymphocytes. In: McMichael, A. J., Fabre, J. W.: Monoclonal antibodies in clinical medicine. Academic Press, New York, 1982, p. 39–70.

    Google Scholar 

  25. Lostrom, M. E., Stone, M. R., Tam, M., Burnette, W. N., Pinter, A., Nowinski, R. C.: Monoclonal antibodies against murine leukemia virus: identification of six antigenic determinants on the p15(E) and gp70 envelope proteins. Virology 1979, 98: 336–350.

    PubMed  Google Scholar 

  26. Meuer, S. C., Schlossman, S. F., Reinherz, E. L.: Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector cells recognize products of different major histocompatibility complex regions. Proceedings of the National Academy of Sciences of the United States of America 1983, 79: 4395–4399.

    Google Scholar 

  27. Fahey, J. L., Prince, H., Weaver, M., Groopman, J., Visscher, B., Schwartz, K., Detels, R.: Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immunodeficiency syndrome from other immune subset disorders. American Journal of Medicine 1984, 76: 95–100.

    PubMed  Google Scholar 

  28. Schooley, R. T., Hirsch, M. S., Colvin, R. B., Cosimi, A. B., Tolkoff-Rubin, N. W., McCluskey, R. T., Burton, R. C., Russell, P. S., Herrin, J. T., Delmouico, F. L., George, J. V., Henle, W., Rubin, R. H.: Association of herpes-virus infections with T lymphocyte subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. New England Journal of Medicine 1983, 308: 307–313.

    PubMed  Google Scholar 

  29. Atkinson, K., Hansen, J. A., Storb, R., Goehle, S., Goldstein, G., Thomas, E. D.: T-cell subpopulations identified by monoclonal antibodies after human bone marrow transplantation I. Helper-inducer and cytotoxic-suppressor subsets. Blood 1982, 59: 1292–1298.

    PubMed  Google Scholar 

  30. Cosimi, A. B., Calvin, R. B., Burton, R. C., Rubin, R. H., Goldstein, G., Kung, P. C., Hanson, W. P., Delmonas, F. L., Russell, P. S.: Use of monoclonal antibodies to T cell subsets for immunological monitoring and treatment in recipients of renal allografts. New England Journal of Medicine 1981, 305: 308–314.

    PubMed  Google Scholar 

  31. Kotzin, B. L., Kansas, G. S., Engleman, E. G., Hoppe, R. T., Kaplan, H. S., Strober, S.: Changes in T cell subsets in patients with rheumatoid arthritis treated with total lymphoid irradiation. Clinical Immunology and Immunopathology 1983, 27: 250–260.

    PubMed  Google Scholar 

  32. Nicholson, J. K., McDougal, J. S., Spira, J. T., Cross, G. D., Jones, B. M., Reinherz, E. L.: Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy. Journal of Clinical Investigation 1984, 73: 191–201.

    PubMed  Google Scholar 

  33. Smolen, J. S., Chused, T. M., Leiserson, W. M., Reeves, J. P., Alling, D., Steinberg, A. D.: Heterogeneity of immunoregulatory T cell subsets in systemic lupus erythematosus. Correlation with clinical features. American Journal of Medicine 1982, 72: 783–790.

    PubMed  Google Scholar 

  34. Morimoto, C., Reinherz, E. L., Distaso, J. A., Schlossman, S. F.: Relationship between systemic lupus erythematosus, T cell subsets, anti T cell antibodies and T cell functions. Journal of Clinical Investigation 1984, 73: 689–700.

    PubMed  Google Scholar 

  35. Nussenblatt, R. B., Salisas-Carmona, M., Leake, W., Scher, I.: T lymphocyte subsets in uveitis. American Journal of Ophthalmology, 1983, 95: 614–621.

    PubMed  Google Scholar 

  36. Misaki, T., Konishi, J., Iida, Y., Endo, K., Torizuka, K.: Altered balance of immunoregulatory T lymphocyte subsets in autoimmune thyroid disease. Acta Endocrinologica 1984, 105: 200–204.

    PubMed  Google Scholar 

  37. Buschard, K., Ropke, C., Madsbad, S., Mehlsen, J., Rygaard, J.: T lymphocyte subsets in patients with newly diagnosed type 1 (insulin dependent) diabetes: a prospective study. Diabetologia 1983, 25: 247–251.

    PubMed  Google Scholar 

  38. Hauser, S. L., Reinherz, E. L., Hoban, C. J., Schlossman, S. F., Weiner, H. L.: Immunoregulatory T cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six month period. Annals of Neurology 1983, 13: 418–425.

    PubMed  Google Scholar 

  39. Rice, G. P., Finney, D., Braheny, S. L., Knobler, R. L., Sipe, J. C., Oldstone, M. B.: Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5 and OKT8. Journal of Neuroimmunology 1984, 6: 75–84.

    PubMed  Google Scholar 

  40. Heuman, D., Candardjis, P., Carrel, S., Mach, J.-P.: Identification of the normal glycoprotein (NGP) cross reacting with CEA as a differentiation antigen of myeloid cells and macrophages. In: Lehmann, F. G. (ed.): Carcinoembryonic Proteins. Volume 2. Elsevier North Holland Biomedical Press, Amsterdam, 1979, p. 3–14.

    Google Scholar 

  41. Mason, D. Y., Gatter, K. C.: Immunohistological analyses of human malignancies with monoclonal antibodies. In: Boss, B. D., Langman, R., Trowbridge, I. S., Dulbecco, R. (ed.): Monoclonal antibodies and cancer. Academic Press, New York, 1983, p. 187–198.

    Google Scholar 

  42. Shen, J. W., Atkinson, B., Koprowski, H., Sears, H. F.: Binding of murine immunoglobulin to human tissues after immunotherapy with anticolorectal carcinoma monoclonal antibody. International Journal of Cancer 1984, 33: 465–468.

    Google Scholar 

  43. Greene, G. L., Nolan, C., Engler, J. P., Jensen, E. V.: Monoclonal antibodies to human estrogen receptor. Proceedings of the National Academy of Sciences of the USA 1980, 77: 5115–5119.

    PubMed  Google Scholar 

  44. Moldofsky, P. J., Sears, H. F., Mulhern, C. B. Jr., Hammond, N. D., Powe, J., Gatenby, R. A., Steplewski, Z., Koprowski, H.: Detection of metastatic tumor in normal-sized retroperitoneal lymph nodes by monoclonal antibody imaging. New England Journal of Medicine 1984, 311: 106–107.

    PubMed  Google Scholar 

  45. Chatal, J. F., Saccavini, J. C., Fumoleau, P., Douillard, J. Y., Curtet, C., Kremer, M., LeMevel, B., Koprowski, H.: Immunoscintigraphy of colon carcinoma. Journal of Nuclear Medicine 1984, 25: 307–314.

    PubMed  Google Scholar 

  46. Jaffers, G., Colvin, R. B., Cosimi, A. B., Giorgi, J. V., Goldstein, G., Fuller, T. C., Kutnick, J. T., Lillehei, C., Russell, P. S.: The human immune response to murine OKT3 monoclonal antibody. Transplantation Proceedings 1983, 15: 648–664.

    Google Scholar 

  47. Chatenoud, L., Baudrihaye, M. F., Kreis, H., Goldstein, G., Bach, J. F.: The restricted antibody human response to the murine monoclonal OKT3 antibody. The Tenth International Congress of the Transplantation Society, Minneapolis, 1984, Abstract S11.2.

  48. Kirkman, R. L., Araujo, J. L., Busch, G. B., Carpenter, C. B., Melford, E. L., Reinherz, E. L., Schlossman, S. F., Strom, T. B., Tilney, N. L.: Treatment of acute renal allograft rejection with monoclonal anti T12 antibody. Transplantation 1983, 36: 620–626.

    PubMed  Google Scholar 

  49. Takahashi, H., Terasaki, P. I., Kinukawa, T., Chia, D., Minra, K., Okasaki, H., Iwaki, Y., Taguchi, Y., Hardiwidjaja, S., Ishizaki, M.: Reversal of transplant rejection by monoclonal antiblast antibody. Lancet 1983, ii: 1155–1157.

    Google Scholar 

  50. Kreis, H., Chkoff, N., Vigeral, P., Chatenoud, L., Lacombe, M., Pampos, H., Pruna, A., Goldstein, G., Bach, J. F., Crosnier, J.: Prophylactic treatment of allograft recipients with a monoclonal anti T3+ cell antibody. The Tenth International Congress of the Transplantation Society, Minneapolis, 1984, Abstract S29.3.

  51. Cosimi, A. B., Burton, R. C., Kung, P. C.: Evaluation in primate renal allograft recipients of monoclonal antibody to human T cell subclasses. Transplantation Proceedings 1981, 13: 499–503.

    PubMed  Google Scholar 

  52. Jonker, M., Goldstein, G., Balner, H.: Effects of in vivo administration of monoclonal antibodies specific for human T cell population with immune system of a rhesus monkey model. Transplantation 1983, 35: 521–526.

    PubMed  Google Scholar 

  53. Reinherz, E. L., Geha, R., Rappeport, J. M., Wilson, M., Penta, A. C., Hussey, R. E., Fitzgerald, K. A., Daley, J. F., Levine, H., Rosen, F. S., Schlossman, S. F.: Reconstitution after transplantation with T lymphocyte depleted HLA haplotype mismatched bone marrow for severe combined immunodeficiency. Proceedings of the National Academy of Sciences of the United States of America 1982, 79: 6047–6051.

    PubMed  Google Scholar 

  54. Filipovich, A. H., Vallera, D., Kersey, J. H., Quinones, R., Noville, D., Youle, R.: Ex vivo T cell depletion of bone marrow with immunotoxins. Anti pan T monoclonal antibody-ricin conjugates: a new method of graft vs host disease prophylaxis in allogeneic bone marrow. The Tenth International Congress of the Transplantation Society, Minneapolis, 1984, Abstract S20.6.

  55. Martin, P. J., Hansen, J. A., Thomas, E. D.: Depletion of T cells in donor marrow for prevention of graft vs host disease. The Tenth International Congress of the Transplantation Society, Minneapolis, 1984, Abstract S37.6.

  56. Mitsuyasu, R., Champhin, R., Ho, W., Wolls, J., Terasaki, P. I., Billing, R., Gale, R. P.: Randomized controlled trial of bone marrow transplantation after in vitro treatment with monoclonal anti T cell antibody and complement: preliminary report. The Tenth International Congress of the Transplantation Society, Minneapolis, 1984, Abstract S37.5.

  57. O'Reilly, R. J., Collins, N., Brochstein, J., Dinsmore, R., Kirkpatrick, D., Kernan, N., Siena, S., Shank, B., Wolf, L., Dupont, B., Reisner, Y.: Transplantation of HLA non-identical marrow depleted of T cells by soybean agglutination and E-rosette depletion: possible MHC-related graft resistance in leukemic transplant recipients. The Tenth International Congress of the Transplantation Society, Minneapolis, 1984, Abstract S31.5.

  58. Filipovich, A. H., McGlave, P. B., Ramsay, N. K., Goldstein, G., Warkentin, P. I., Kersey, J. H.: Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus host disease in allogeneic histocompatible bone-marrow transplantation. Lancet 1982, i: 1266–1269.

    Google Scholar 

  59. Baumgartner, C., Imbach, P., Luthy, A., Odavic, R., Wagner, H. P., Brun del Re, G., Bucher, V., Forster, H. K., Hirt, A., Mozell, A.: Autologous bone marrow transplantation for stage IV abdominal non-Hodgkin's lymphoma after in vitro purging with anti-Y29/55 monoclonal antibody and complement. In: Boss, B. D., Langman, R., Trowbridge, I. S., Dulbecco R. (ed.): Monoclonal antibodies and cancer. Academic Press, New York, 1983, p. 74–79.

    Google Scholar 

  60. Miller, R. A., Maloney, D. G., Warnke, R., Levy, R.: Treatment of a B cell lymphoma with monoclonal antiidiotype antibody. New England Journal of Medicine 1982, 306: 517–522.

    PubMed  Google Scholar 

  61. Trowbridge, I. S.: Therapeutic potential of monoclonal antibodies that block biological function. In: Boss, B. D., Langman, R., Trowbridge, I. S., Dulbecco, R. (ed.): Monoclonal antibodies and cancer. Academic Press, New York, 1983, p. 63–61.

    Google Scholar 

  62. Levy, R., Miller, R. A., Statte, P. T., Maloney, D. G., Link, M. P., Muker, T. C., Oseroff, A., Thielemans, K., Warnke, R.: Therapeutic trials of monoclonal antibody in leukemia and lymphoma: biologic considerations. In: Boss, B. D., Langman, R., Trowbridge, I. S., Dulbecco, R. (ed.): Monoclonal antibodies and cancer. Academic Press, New York, 1983, p. 5–16.

    Google Scholar 

  63. Sears, H. F., Herlyn, D., Steplewski, Z., Koprowski, H.: Effects of monoclonal antibody immunotherapy on patients with gastrointestinal carcinoma. Journal of Biological Response Modifiers 1984, 3: 138–150.

    PubMed  Google Scholar 

  64. Vitetta, E. S., Krolick, K. A., Miyama-Inaba, M., Cushley, W., Uhr, J. W.: Immunotoxins: a new approach to cancer therapy. Science 1983, 219: 644–650.

    PubMed  Google Scholar 

  65. Uhr, J. W., Vitetta, E. S.: The use of immunotoxins for the treatment of cancer. In: Boss, B. D., Langman, R., Trowbridge, I. S., Dulbecco, R. (ed.): Monoclonal antibodies and cancer. Academic Press, New York, 1983, p. 85–98.

    Google Scholar 

  66. Adelman, N. E., Watting, D. L., McDevitt, H. O.: Treatment of (NZB x NZW) F1 disease with anti I-A monoclonal antibodies. Journal of Experimental Medicine 1983, 158: 1350–1355.

    PubMed  Google Scholar 

  67. Waldor, M. K., Sriram, S., McDevitt, H. O., Steinman, L.: In vivo therapy with monoclonal anti I-A antibody suppresses immune responses to acetycholine receptor. Proceedings of the National Academy of Sciences of the United States of America 1983, 8: 2713–2717.

    Google Scholar 

  68. Radka, S. F., Amos, D. B., Quackenbush, L. J., Cresswell, P.: HLA-DR7-specific monoclonal antibodies and a chimpanzee anti-DR7 serum detect different epitopes on the same molecule. Immunogenetics 1984, 19: 63–76.

    PubMed  Google Scholar 

  69. Kennedy, R. C., Dreesman, G. R.: Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that express a similar idiotype. Journal of Experimental Medicine 1984, 159: 655–665.

    PubMed  Google Scholar 

  70. Smith, G. L., Godson, G. N., Nussenzweig, V., Nussenzweig, R. S., Barnwell, J., Moss, B.:Plasmodium knowlesi sporozoite antigen: expression by recombinant vaccinia virus. Science 1984, 224: 397–399.

    PubMed  Google Scholar 

  71. Cohen, S.: Monoclonal antibodies in parasitology, with particular reference to malaria. In: McMichael, A. J., Fabre, J. W. (ed.): Monoclonal antibodies in clinical medicine. Academic Press, New York, 1982, p. 311–331.

    Google Scholar 

  72. Olsson, L., Kaplan, H. S.: Human-human hybridomas producing monoclonal antibodies of predefined specificity. Proceedings of the National Academy of the Sciences of the United States of America 1980, 77: 5429–5431.

    Google Scholar 

  73. Croce, C. M., Linnenbach, A., Hall, W., Steplewski, Z., Koprowski, H.: Production of human hybridomas secreting antibodies to measles virus. Nature 1980, 288: 488–489.

    PubMed  Google Scholar 

  74. Reed, E., Bonagura, V., Kung, P., King, D. W., Suciu-Foca, N.: Anti-idiotypic antibodies to HLA-DR4 and DR2. Journal of Immunology 1983, 131: 2890–2894.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute of Allergy and Infectious Diseases, National institutes of Health and Office of Research, Health Care Financing Administration, 21207, Baltimore, Maryland, USA

    H. Krakauer

Authors
  1. H. Krakauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krakauer, H. Clinical applications of monoclonal antibodies. Eur. J, Clin. Microbiol. 4, 1–9 (1985). https://doi.org/10.1007/BF02148651

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02148651

Keywords

Search

Navigation